Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 6, 2021Gene TherapyOpen Access

Non-viral delivery of CRISPR–Cas9 complexes for targeted gene editing via a polymer delivery system

View Full Paper
Ask AI
Bookmark
Share

Authors

JAJonathan O’Keeffe AhernUniversity College DublinILIrene Lara‐SáezUniversity College DublinDZDezhong ZhouXi'an Jiaotong University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ahern et al. (2021) studied this question.

synapsesocial.com/papers/6aaba62e1bb6b918d8ca2f92https://doi.org/10.1038/s41434-021-00282-6
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Development of Branched Poly(5-Amino-1-pentanol-<i>co</i>-1,4-butanediol Diacrylate) with High Gene Transfection Potency Across Diverse Cell Types2016 · 45 citations
  2. 2A non‐viral gene therapy for treatment of recessive dystrophic epidermolysis bullosa2016 · 33 citations
  3. 3Non-viral Delivery of Nucleic Acids: Insight Into Mechanisms of Overcoming Intracellular Barriers2018 · 243 citations
  4. 4A Combinatorial Polymer Library Approach Yields Insight into Nonviral Gene Delivery2008 · 588 citations
  5. 5Comparative Study on the In Vitro Cytotoxicity of Linear, Dendritic, and Hyperbranched Polylysine Analogues2012 · 115 citations